Pages that link to "Q39392454"

The following pages link to Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy (Q39392454):

Displaying 31 items.

• Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome (Q21091076) (← links)
• Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome (Q21133920) (← links)
• Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome (Q24647883) (← links)
• Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. (Q33450566) (← links)
• Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship. (Q33624179) (← links)
• Patient and practitioner influences on the placebo effect in irritable bowel syndrome (Q33636363) (← links)
• Placebo responses in patients with gastrointestinal disorders (Q34098616) (← links)
• Effect of Colostrum on the Symptoms and Mucosal Permeability in Patients with Irritable Bowel Syndrome: A Randomized Placebo-controlled Study. (Q34378514) (← links)
• Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database. (Q34764154) (← links)
• Effectiveness of nasal irrigation for chronic rhinosinusitis and fatigue in patients with Gulf War illness: protocol for a randomized controlled trial (Q35288098) (← links)
• Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels (Q35584944) (← links)
• The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome (Q36309936) (← links)
• Patient-reported outcomes in gastroenterology: clinical and research applications (Q36817391) (← links)
• Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles (Q37164063) (← links)
• A treatment trial of acupuncture in IBS patients (Q37223914) (← links)
• Adequate relief in a treatment trial with IBS patients: a prospective assessment (Q37253528) (← links)
• Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report (Q37475280) (← links)
• Current and emerging pharmacotherapeutic options for irritable bowel syndrome (Q38254747) (← links)
• A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS. (Q39335358) (← links)
• Integrative treatment approaches: family satisfaction with a multidisciplinary paediatric Abdominal Pain Clinic (Q41843018) (← links)
• Study design considerations for irritable bowel syndrome clinical trials. (Q42934168) (← links)
• Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials (Q43313282) (← links)
• Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients (Q46896431) (← links)
• A pilot study to assess the efficacy of biofeedback-assisted relaxation training as an adjunct treatment for pediatric functional dyspepsia associated with duodenal eosinophilia. (Q48875599) (← links)
• A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder (Q50343808) (← links)
• The Ausback study: an audit of low back pain outcomes in Australian musculoskeletal medicine practices (Q57198169) (← links)
• Cognitive behavioral therapy with interoceptive exposure and complementary video materials for irritable bowel syndrome (IBS): protocol for a multicenter randomized controlled trial in Japan. (Q64891594) (← links)
• Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study (Q89017767) (← links)
• Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (Q89530606) (← links)
• Low FODMAP diet in children and adolescents with functional bowel disorder: A clinical case note review (Q91844641) (← links)
• Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial (Q97557107) (← links)